Vonoprazan (Voquezna) was noninferior to lansoprazole (Prevacid) for healing patients with erosive esophagitis, and was superior for maintaining healing, a randomized trial showed. In a modified ...

Credit: Phathom Pharmaceuticals. Voquezna, a potassium-competitive acid blocker, is supplied as 10mg and 20mg tablets. Voquezna ® (vonoprazan) is now available for the treatment of erosive esophagitis ...

The oral potassium-competitive acid blocker (PCAB) vonoprazan was noninferior and superior to the proton pump inhibitor (PPI) lansoprazole for erosive esophagitis, according to results of the phase 3 ...

The US Food and Drug Administration (FDA) has approved vonoprazan 10 mg and 20 mg tablets (Voquezna, Phathom Pharmaceuticals) for the healing and maintenance of healing of all grades of erosive ...

throat The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis. The New ...

The FDA approved vonoprazan (Voquezna) for all grades of erosive gastroesophageal reflux disease (GERD) and heartburn relief associated with the condition, Phathom Pharmaceuticals announced on ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 63 years old, and four weeks ago, I was diagnosed by my ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Phathom Pharmaceuticals’ Voquezna tablets 10 mg and 20 mg to treat erosive esophagitis, or ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today announced its ...

Phathom Pharmaceuticals PHAT stock jumped 8.42% on Tuesday after the company announced a positive outcome from a recent meeting with the FDA regarding the resubmission of its new drug application (NDA ...

Phathom Pharmaceuticals' erosive esophagitis drug vonoprazan performed as well as over-the-counter Prevacid in a head-to-head phase 3 clinical trial, potentially teeing up a 2022 application for FDA ...

Dear Dr. Roach: I am 63 years old, and four weeks ago, I was diagnosed by my gastroenterologist with erosive esophagitis after an endoscopy. I was placed initially on Protonix, but I didn’t improve ...